OPM Biosciences, a cell culture media and bioprocess solutions company, today announced two new offerings that extend its OPM-CHO™ platform into biosimilar development and manufacturing: the ...
By David Kirton and Nicoco Chan CHANGZHOU, China, Sept 22 (Reuters) - A US battery startup that scrapped plans to make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results